Molecular mechanisms of varicella zoster virus pathogenesis.
Zerboni L, Sen N, Oliver SL, Arvin AM.
Nat Rev Microbiol. 2014 Mar;12(3):197-210. doi: 10.1038/nrmicro3215. Epub 2014 Feb 10.
Varicella-zoster virus.
Arvin AM.
Clin Microbiol Rev. 1996 Jul;9(3):361-81. doi: 10.1128/CMR.9.3.361.
Pathogenesis and current approaches to control of varicella-zoster virus infections.
Gershon AA, Gershon MD.
Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13.
Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS.
Rev Med Virol. 2024 Jul;34(4):e2554. doi: 10.1002/rmv.2554.
Varicella-Zoster Virus Infection of Neurons Derived from Neural Stem Cells.
Kennedy PGE, Mogensen TH.
Viruses. 2021 Mar 15;13(3):485. doi: 10.3390/v13030485.
Varicella-zoster virus latency.
Croen KD, Straus SE.
Annu Rev Microbiol. 1991;45:265-82. doi: 10.1146/annurev.mi.45.100191.001405.
Protection against Severe Varicella Disease.
Choi EH.
J Korean Med Sci. 2019 Mar 12;34(10):e93. doi: 10.3346/jkms.2019.34.e93. eCollection 2019 Mar 18.
Varicella vaccine.
Ellis RW.
Vaccine. 1995;13(15):1387-8. doi: 10.1016/0264-410x(95)00135-n.
Varicella.
Sullivan-Bolyai JZ, Smith AL.
Am J Dis Child. 1981 Oct;135(10):895. doi: 10.1001/archpedi.1981.02130340007003.
Varicella in pediatric patients.
Drwal-Klein LA, O'Donovan CA.
Ann Pharmacother. 1993 Jul-Aug;27(7-8):938-49. doi: 10.1177/106002809302700723.
